Évaluation thérapeutique des tumeurs solides – Session 6

Olivier Humbert, Jean-Marc Riedinger, Céline Charon-Barra, Alina Berriolo-Riedinger, Isabelle Desmoulins, Véronique Lorgis, Salim Kanoun, Charles Coutant, Pierre Fumoleau, Alexandre Cochet, François Brunotte, Identification of biomarkers including 18FDG-PET/CT for early prediction of response to neoadjuvant chemotherapy in Triple Negative Breast Cancer Clinical Cancer Research. ,vol. 21, pp. 5460- 5468 ,(2015) , 10.1158/1078-0432.CCR-15-0384

Lode Goethals, Sofie Wilgenhof, Frank De Geeter, Hendrik Everaert, Bart Neyns, 18F-FDG PET/CT imaging of an anti-CTLA-4 antibody-associated autoimmune pancolitis. European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 38, pp. 1390- 1391 ,(2011) , 10.1007/S00259-011-1749-5

Laurent Dercle, Roland Chisin, Samy Ammari, Quentin Gillebert, Monia Ouali, Cyril Jaudet, Jean-Pierre Delord, Lawrence Dierickx, Slimane Zerdoud, Martin Schlumberger, Frédéric Courbon, Nonsurgical giant cell tumour of the tendon sheath or of the diffuse type: are MRI or 18F-FDG PET/CT able to provide an accurate prediction of long-term outcome? European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 42, pp. 397- 408 ,(2015) , 10.1007/S00259-014-2938-9

David Groheux, Elif Hindié, Sylvie Giacchetti, Anne-Sophie Hamy, Frederique Berger, Pascal Merlet, Anne de Roquancourt, Patricia de Cremoux, Michel Marty, Mathieu Hatt, Marc Espié, Early assessment with 18F-fluorodeoxyglucose positron emission tomography/computed tomography can help predict the outcome of neoadjuvant chemotherapy in triple negative breast cancer. European Journal of Cancer. ,vol. 50, pp. 1864- 1871 ,(2014) , 10.1016/J.EJCA.2014.04.020

M. H. van Gool, T. S. Aukema, E. E. Schaake, H. Rijna, R. A. Valdes Olmos, R. van Pel, S. A. Burgers, H. van Tinteren, H. M. Klomp, , Timing of Metabolic Response Monitoring During Erlotinib Treatment in Non–Small Cell Lung Cancer The Journal of Nuclear Medicine. ,vol. 55, pp. 1081- 1086 ,(2014) , 10.2967/JNUMED.113.130674

Kenneth E. Pengel, Bas B. Koolen, Claudette E. Loo, Wouter V. Vogel, Jelle Wesseling, Esther H. Lips, Emiel J. Th. Rutgers, Renato A. Valdés Olmos, Marie Jeanne T. F. D. Vrancken Peeters, Sjoerd Rodenhuis, Kenneth G. A. Gilhuijs, Combined use of 18F-FDG PET/CT and MRI for response monitoring of breast cancer during neoadjuvant chemotherapy European Journal of Nuclear Medicine and Molecular Imaging. ,vol. 41, pp. 1515- 1524 ,(2014) , 10.1007/S00259-014-2770-2

Phillip J. Koo, William C. Klingensmith, Karl D. Lewis, Brian M. Bagrosky, Rene Gonzalez, Anti-CTLA4 Antibody Therapy Related Complications on FDG PET/CT Clinical Nuclear Medicine. ,vol. 39, pp. e93- e96 ,(2014) , 10.1097/RLU.0B013E318292A775

David Groheux, Elif Hindié, Sylvie Giacchetti, Marc Delord, Anne-Sophie Hamy, Anne de Roquancourt, Laetitia Vercellino, Nathalie Berenger, Michel Marty, Marc Espié, Triple-Negative Breast Cancer: Early Assessment with 18F-FDG PET/CT During Neoadjuvant Chemotherapy Identifies Patients Who Are Unlikely to Achieve a Pathologic Complete Response and Are at a High Risk of Early Relapse The Journal of Nuclear Medicine. ,vol. 53, pp. 249- 254 ,(2012) , 10.2967/JNUMED.111.094045

Bruno Coudert, Jean-Yves Pierga, Marie-Ange Mouret-Reynier, Kaldoun Kerrou, Jean-Marc Ferrero, Thierry Petit, Pierre Kerbrat, Pierre-François Dupré, Thomas Bachelot, Philippe Gabelle, Sylvia Giard, David Coeffic, Philippe Bougnoux, Jean-Briac Prevost, Gilles Paintaud, Gilles Thibault, Juana Hernandez, Mathieu Coudert, Laurent Arnould, Alina Berriolo-Riedinger, Use of [18F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [18F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial Lancet Oncology. ,vol. 15, pp. 1493- 1502 ,(2014) , 10.1016/S1470-2045(14)70475-9

Bhumsuk Keam, Seock-Ah Im, Youngil Koh, Sae-Won Han, Do-Youn Oh, Nariya Cho, Jee Hyun Kim, Wonshik Han, Keon Wook Kang, Woo Kyung Moon, Tae-You Kim, In Ae Park, Dong-Young Noh, June-Key Chung, Yung-Jue Bang, Early metabolic response using FDG PET/CT and molecular phenotypes of breast cancer treated with neoadjuvant chemotherapy BMC Cancer. ,vol. 11, pp. 452- 452 ,(2011) , 10.1186/1471-2407-11-452